Investment Q&A

Q: What covid 19 vaccine stocks would you recommend --- if ay Pfizer, Moderna, Johnson and Johnson, Astro Zeneca or others.

Q: On a steady decline since $8.41 on Oct 16,though seems to have found support around $6.70-6.86 near the $6.75 Bought Deal price. This morning Well announced that it will be profitable in the Q.Is it unusual to preannounce? When will it reports the Q?.Is it timely to set up a position here especially in light of approval & subsequent distribution of Vaccine? Txs for u usual great services & views

Q: Good morning... Wondering your thoughts on TRIL's clinical trial results, if there are any catalysts in the pipeline and if it's worth a buy at current levels.

thx, Mark

Q: Hi,
I am interested in your thoughts on these companies. EXAS and CRSP are a part of the recently fast moving ARKG ETF but both seem to offer products that would appear to offer continued growth. Would that be correct? The other two, VEEV and SGEN have been struggling price wise lately, SGEN is starting to see improvement, do you think VEEV still has good potential into the next year or two? I've also noticed more comments on Unity Software, but do not know much about it and it isn't listed in your data base. Take as many points as you need, as I'm asking multiple questions. Thanks for all your insight and suggestions, all very much appreciated!
Dawn

Q: Hi,

Now that the IPO has come out and the feeding frenzy pushed the stock to approx $71 on day one, it has retraced quite a bit from that one day high but still double the IPO price today (Dec 15). I will wait for this one to settle a bit more in the next several weeks but just curious what you think a fair entry price range would be given they are already profitable vs several other recent IPO's in the same space or other space for that matter? Or should one wait for the outcome of phase 2 and 3 trials before dipping their toes in on this one? I would only initiate a 1/3 position.
I realize the euphoria right now is around covid but longer term they seem to have a unique product/platform that could be applicable elsewhere, ie AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health.

Cheers....

Q: I am trying to understand Pfizer. In September it was trading at $36 and change. Today after all the good news about the vaccine it is at $39 and change. This seems like a small increase given the good it is doing and news, etc. However, if there were reports of a few bad reactions (or worse, sorry to say), the stock would tank. Can you help me understand this or maybe I am seeing it all wrong. Thanks again.

Q: Receuved a notice of ipo for MCI OneHealth Technologies Inc. Do you have any information you can share on this one?

Q: I have owned CRH medical for quite sometime and it has not done to much for me. Do you think a switch into GUD would be better?

Q: Hi and good day. Could you please provide some worst case scenarios with GUD stock and share price. Thanks eh

Q: THRM can you take a look at this penny stock .... it reads like a real potential success story ....

Q: Could I have your thoughts on BioHaven. It has a new drug for acute treatment of migraine headaches and seems to be very effective. Their stock has progressed since the drug was first put on the market earlier this year. How do they look financially? I believe they have an interest in another company Kleo Pharmaceuticals. I believe The Bill & Melinda Gates Foundation has also given Kleo a substantial grant.
Thanks John

Q: Hi Peter, I'm just wondering about any new views since the 3rd of Sept comment. Would this also be a good play on the vaccine investments for 2021. Each person needs 2 doses - that's a lot of syringes and needles! Would Becton benefit or is there too many competition suppliers out there (market share?) and/or doesn't make too much towards its total annual profits? Thanks.

Q: I would like your opinion on this little stock as it seems to be heading in the covid direction. Thx J

Q: Hi - huge pop on the IPO for AbCellera. Sounds promising, what would your take be on investing in it now? Better to wait for some of the enthusiasm to die down? Looks like it has a strong US following.

Q: I read that GUD would be delisted from S&P/TSX. What would be the reasons? Any suggestion?

Q: What portion of FHI distribution is return of capital? What would be your order of choice among LIFE; FHI; and HHL ?

Q: Can you comment on any recent insider buying or selling for GUD. E.g. has the CEO bought any large chunks? I am curious if there has been some insider purchasing/selling either before or after the shelf filing. If there has been buying, what do you think are the odds that there might be an acquisition in the works. I bought GUD at $5 and am trying to decide whether to hold, sell, or top up. Because everything else in my portfolio has done so well this year (all fantastic 5i suggestions), GUD has decreased to 1.3% of total holdings.

Q: Hi guys. Would you be able to tell me your ratings on these medical stocks for growth and risk please. It would be a 3 year time frame minimum. Thks again for the great job you do.

Q: Hello 5i
Could I have your opinion in PNSL please?
Also who would their competitors be?
Thank you
Dave

Q: GUD has roughly 400M in cash. Getting 360M with a share offering will get them 760M.
With that money how big an acquisition could it be if that was their intention ? Also, how long does it take normally take for for the shelf prospectus to be approved ?
Thanks